3 studies were found.

1.		No longer recruiting	Breast-Conserving Therapy Compared With Mastectomy Followed By Radiation Therapy in Treating Women With Locally Advanced Breast Cancer Previously Treated With Chemotherapy Conditions: stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; inflammatory breast cancer
2.		Recruiting	Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer Conditions: stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
3.		No longer recruiting	Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer Conditions: stage III breast cancer; stage I breast cancer; stage II breast cancer